Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol
W. Maruyama et al., Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, J NEUROCHEM, 78(4), 2001, pp. 727-735
An endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, was found to
induce apoptosis in human dopaminergic SH-SY5Y cells by step-wise activatio
n of apoptotic cascade; collapse in mitochondrial membrane potential, Delta
Psim, activation of caspases, and fragmentation of DNA. Recently, accumula
tion of gylceraldehyde-3-phosphate dehydrogenase (GAPDH) in nuclei was prop
osed to play an important role in apoptosis. In this paper, involvement of
GAPDH in apoptosis induced by N-methyl(R)salsolinol was studied. The isoqui
noline reduced Delta Psim within 3 h, as detected by a fluorescence indicat
or, JC-1, then after 16 h incubation, GAPDH accumulated in nuclei by detect
ion with immunostaining. To clarify the role of GAPDH in apoptotic process,
a stable cell line of Bcl-2 overexpressed SH-SY5Y cells was established. O
verexpression of Bcl-2 prevented the decline in Delta Psim and also apoptot
ic DNA damage induced by N-methyl(R)salsolinol. In Bcl-2 transfected cells,
nuclear translocation of GAPDH was also completely suppressed. In addition
, a novel antiparkinsonian drug, rasagiline, prevented nuclear accumulation
of GAPDH induced by N-methyl(R)salsolinol in control cells. These results
suggest that GAPDH may accumulate in nuclei as a consequence of signal tran
sduction, which is antagonized by anti-apoptotic Bcl-2 protein family and r
asagiline. The results are discussed in concern to intracellular mechanism
underlying anti-apoptotic function of rasagiline analogues.